Bioresorbable Stents Market - Forecast(2021 - 2026)

Report Code: HCR 1365 Report Format: PDF + Excel (Delivery in 48 Hrs)
Bioresorbable Stents Market Overview 
Bioresorbable Stents Market size is valued at $ 31,779 thousand in 2019, and is estimated to reach $36,489 thousand by 2025, growing at CAGR of 2.6% during the forecast period of 2020-2025. The Bioresorbable Stents Market growth rate is attributed to the high prevalence of cardiovascular diseases, steep increase in the aging population, and the expanding base of the obese population coupled with busy lifestyle, unhealthy foods and less physical activity increase the chances of having cardiovascular disease and foster the market growth. The devices are generally made of metallic or plastic tubes used for the treatment of blockades of the arteries in the heart. Traditionally, stents are made of metal mesh and remain in the body permanently until they are removed through surgical intervention. But nowadays, bioresorbable stents, also known as biodegradable stents, are made of materials which get dissolved or absorbed in the body. A bioresorbable stent has no permanent implant. It gets gradually resorbed and benignly cleared from the body. From technological advancement to develop more innovative bioabsorbable stents to increased R&D investments by governmental bodies to overcome limitations of high cost is anticipated to propel the Bioresorbable Stents Market during the forecast period 2020-2025.   

Report Coverage
The report: “Bioresorbable Stents Market Forecast (2020-2025)”, by Industry ARC, covers an in-depth analysis of the following segments of the Bioresorbable Stents Market: 

By Product Type:  Coronary stent, Neurology stent, Ureteral stent and Biliary stent.
By Absorption Rate: Slow- absorption stents and Fast- absorption stents.
By Material Type: Polymeric stents and Metallic stents.
By Application: Cardiovascular system and Digestive system.
By Geography: North America, Europe, Asia-Pacific and RoW.

Key Takeaways
  • Europe dominated the Bioresorbable Stents Market with a share of 41% in the year 2019.        
  • The factors such as increasing priority for improvement of health in developing countries, growing opportunities of percutaneous coronary intervention procedures are amongst the major factor projected to impel growth of Bioresorbable Stents Market.
  • Increased need for bioabsorbable stents globally is owing to patients with bioabsorbable stents experience much less discomfort owing to the less invasive procedure, significant increase in population with a cholesterol-rich diet coupled with increase in the population of smokers and are the key factors owing to the growth in the segment during forecast period 2020-2025.

Product Type - Segment Analysis
Coronary stent segment held the largest share in the market owing to increasing demand for bioabsorbable stents that can be used in coronary procedures and growing preference for minimally invasive surgical procedures over other stents as Increasing obese population and high prevalence of coronary artery diseases. Also, coronary stent can improve symptoms of blocked arteries, such as chest pain and shortness of breath. It is often used during a heart attack to quickly open a blocked artery and reduce the amount of damage to the heart. Moreover, coronary stent is used to treat narrowed or blocked coronary arteries and can also be used to improve blood flow immediately following a heart attack, with a goal to fully support the vessel during this critical period and then resorb from the body when it is no longer needed.
   
Application Type- Segment Analysis
On the basis of Application type, peripheral artery segment of the cardiovascular segment held the major share of the market in terms of revenue and is estimated to grow with a CAGR of 2.6%. The reason is set to be attributed to the fact that it is a common circulatory problem in which narrowed arteries reduce blood flow to limbs with a sign of more widespread accumulation of fatty deposits in arteries that is atherosclerosis which reduces blood flow to heart and brain. Moreover, the cause of peripheral artery disease can be blood vessel inflammation, injury to limbs, unusual anatomy of ligaments, or radiation exposure which can be attributed to the steep increase in the aging population, and the expanding base of the obese population coupled with busy lifestyle, unhealthy foods and less physical activity thereby, increasing the chances, is anticipated to further expand the market over the projection period of 2020-2025. 

By Geography - Segment Analysis
Europe is the major region dominating the bioresorbable stents market with revenue of $13,030 thousand in 2019 and is estimated to grow at a CAGR of 2.5% during the forecast period of 2020-2025 to generate revenue of $14.851 thousand in 2025. There is a rise in the usage owing to the region has a large number of people suffering from cardiovascular diseases and thereby posing a huge demand for technologically advanced treatment options for the same. Moreover, the region is set to increase its market share in the future, owing to the increased usage of bioabsorbable stents. Significant investment is done on R&D activities in U.K. The ORBITA trial, led by researchers funded by the NIHR Imperial BRC Cardiovascular Theme, was the first research study – including over 200 patients with stable angina – where the researchers compared stenting (artery-widening coronary angioplasty with stent or Percutaneous Coronary Intervention) with a simulated procedure but where a stent was not implanted (placebo). Depending on the way cost analysis for various healthcare sectors, the health costs in the different countries and the acceptable marginal cost threshold to avoid an adverse event, the use of a drug-eluting stent in France is cost-effective in the overall population of stented patients.

Drivers – Bioresorbable Stents Market
  • Increasing prevalence of coronary artery diseases and peripheral artery diseases  
With the steep increase in the aging population, and the expanding base of the obese population coupled with busy lifestyle, unhealthy foods and less physical activity; there has been a significant increase in population with a cholesterol-rich diet and smoking habits since the last decade. The increase in the population of smokers is analysed to add up the risk of atherosclerosis along with hypercholesterolemia. These habits and lifestyle changes are estimated to increase the risk of Cardiovascular Diseases (CVDs) and Peripheral Artery Disease (PAD) which can be considered as a Bioresorbable Stents key driver of the market during the forecast period 2020-2025. 
  
Challenges – Bioresorbable Stents Market
  • High selling price and risks of complications associated with bioabsorbable stents
The major challenge for the market is the high cost of devices and drawbacks such as local inflammation recoil after expansion, crossing issues, and difficulty in visualizing a non-metallic stent on fluoroscopy in a vast and heterogeneous market. In addition to these substitutes, there are various other substitutes available for treating blocked arteries as well as CAD and PAD. The stringent rules and regulations scenario, owing to which only a few products have been approved till now is the major problem for some of the regions. 

Bioresorbable Stents Industry Outlook
Product launches, mergers and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the Bioresorbable Stents Market. In 2019, Bioresorbable Stents Market share is fragmented by the top ten players present in the market. Bioresorbable Stents Market top 10 companies are Biotronik, Meril Life Sciences Pvt. Ltd., Arterius, Elixir Medical Corporation, Terumo Corporation, Abbott Laboratories, REVA Medical, Kyoto Medical Planning Co. Ltd,   and others.

Acquisitions/Product Launches
  • In February 2020, Biotronik launched Next-Generation Drug Eluting Stent System in the CE region.
  • In April 2019, Arterius collaborated with University of Bristol’s Translational Biomedical Research Centre to develop a smart bioresorbable stent for severe peripheral vascular disease.

1. Bioresorbable Stents Market Overview
    1.1 Definitions and Scope
2. Bioresorbable Stents Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Product Type
    2.3 Key trends by Application
    2.4 Key trends by Geography
3. Bioresorbable Stents Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Bioresorbable Stents Market - Startup Companies Scenario (Premium)
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Bioresorbable Stents Market – Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Bioresorbable Stents Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Bioresorbable Stents Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Bioresorbable Stents Market – By Product Type (Market Size –$Million/$Billion)
    8.1 Coronary stent
    8.2 Neurology Stent
    8.3 Ureteral Stent
    8.4 Biliary Stent
9. Bioresorbable Stents Market – By Absorption Rate (Market Size –$Million/$Billion)
    9.1 Slow- absorption Stents
    9.2 Fast- absorption Stents
10. Bioresorbable Stents Market – By Material Type (Market Size –$Million/$Billion)
    10.1 Polymeric Stents
        10.1.1 PLLA
        10.1.2 Desaminotryosine Polycarbonate
    10.2 Metallic Stents
        10.2.1 Iron
        10.2.2 Zinc
        10.2.3 Magnesium
        10.2.4 Platinum
11. Bioresorbable Stents Market – By Application (Market Size –$Million/$Billion)
    11.1 Cardiovascular System
        11.1.1 Coronary Arteries
        11.1.2 Peripheral Arteries
    11.2 Digestive System
        11.2.1 Esophageal
12. Bioresorbable Stents Market – By End-Use (Market Size –$Million/$Billion)
    12.1 General Hospitals
    12.2 Cardiac Centers
    12.3 Surgical Centers
13. Bioresorbable Stents Market - By Geography (Market Size –$Million/$Billion)
    13.1 North America
        13.1.1 U.S.
        13.1.2 Canada
        13.1.3 Mexico
    13.2 Europe
        13.2.1 U.K.
        13.2.2 Germany
        13.2.3 France
        13.2.4 Italy
        13.2.5 Spain
        13.2.6 Rest of Europe
    13.3 Asia-Pacific
        13.3.1 China
        13.3.2 India
        13.3.3 Japan
        13.3.4 South Korea
        13.3.5 Australia & New Zealand
        13.3.6 Rest of Asia-Pacific
    13.4 Rest of the World
        13.4.1 Middle East
        13.4.2 Africa
        13.4.3 South America
14. Bioresorbable Stents Market - Entropy
15. Bioresorbable Stents Market – Industry/Segment Competition Landscape  (Premium) 
    15.1 Market Share Analysis
        15.1.1 Global Market Share – Key Companies
        15.1.2 Market Share by Region – Key companies
        15.1.3 Market Share by Countries – Key Companies
        15.1.4 Best Practices for Companies
16. Bioresorbable Stents Market – Key Company List by Country Premium (Premium)
17. Bioresorbable Stents Market Company Analysis
    17.1 Company 1
    17.2 Company 2
    17.3 Company 3
    17.4 Company 4
    17.5 Company 5
    17.6 Company 6
    17.7 Company 7
    17.8 Company 8
    17.9 Company 9
    17.10 Company 10 and more
"*Financials for private companies would be provided on a best efforts basis”.